Home > News > Arrowhead Accelerates Capital Contribution to Insert Therapeutics
October 11th, 2005
Arrowhead Accelerates Capital Contribution to Insert Therapeutics
Abstract:
Arrowhead Research Corp. has accelerated its investment of an additional $3 million to majority-owned subsidiary Insert Therapeutics, Inc.
Source:
businesswire
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanomedicine
Nano-needles for cells May 25th, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
Announcements
Nano-needles for cells May 25th, 2013
How do cold ions slide May 24th, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013